Welcome to GeorgiaLifeScience.com
GeorgiaLifeScience.com is part of a specialized network of state- and province-based biotechnology, medical device,
and life science sites that includes more than 4,500 biotechnology, medical device, pharmaceutical companies,
non-profit research institutions, universities and supporting service sector companies across the U.S. and Canada.
This network addresses the growing informational and service needs of companies, patients, educators and others in
their respective states while providing clients the opportunity to cost effectively
advertise their job openings, events, facility availability and other services at the state level,
regionally or nationwide. We welcome your comments, suggestions and requests for informational content and supporting
services.
 More...
Destination Georgia
Are you considering a move to Georgia? Relocating your business to
Georgia? Starting a company? Or just interested in Georgia?
This section will answer many of your questions regarding the life science industry in Georgia, the province's
economy, tax structure and cost of living, education, transportation, climate, recreational opportunities, history,
industry resources, and more.
More...
|
|
|
Local News...
Free News Release Posting & Archiving Service
- Bristol-Myers Squibb comments on Eli Lilly as new Erbitux marketing partner Eli Lilly and Company announced that it will acquire ImClone Systems for $70 per share, or approximately $6.5 billion. Bristol-Myers Squibb Company currently owns approximately 16.6 percent of all outstanding shares of ImClone.
Bristol-Myers Squibb Company October 06, 2008
- Rifaximin demonstrates highly statistically significant results in prevention of HE Salix Pharmaceuticals announced the successful completion and outcome of its pivotal Phase 3 trial to evaluate the efficacy, safety and tolerability of rifaximin in preventing hepatic encephalopathy, or HE.
Salix Pharmaceuticals, Ltd. October 06, 2008
- Salix presents new Phase II data evidence demonstrating the clinical utility of rifaximin Salix Pharmaceuticals announced findings from two analyses of a Phase II clinical trial that demonstrate the utility of rifaximin, a non–absorbed, gut–selective antibiotic, in the treatment of patients with diarrhea–predominant irritable bowel syndrome (IBS).
Salix Pharmaceuticals, Inc. October 06, 2008
- Sirion Therapeutics launches Durezol for postoperative ocular inflammation and pain Sirion Therapeutics announced that Durezol(TM) 0.05% is now commercially available. Durezol, which was approved by the U.S. Food and Drug Administration in June 2008, is a topical ophthalmic corticosteroid indicated for the treatment of inflammation and pain associated with ocular surgery.
Sirion Therapeutics, Inc. October 06, 2008
- Lilly to acquire ImClone Systems in $6.5 billion transaction Eli Lilly and Company and ImClone Systems announced that the boards of directors of both companies have approved a definitive merger agreement under which Lilly will acquire ImClone through an all cash tender offer of $70.00 per share, or approximately $6.5 billion.
ImClone Systems Inc. October 06, 2008
More... | Submit News Release | National News
|
New Job Postings...
Free Job Posting Trial Offer
More... |
Job Advertising...
| About Job Postings...
|
New Facilities Available...
ATC clean room constructors...validation guaranteed!
More... |
Facility Advertising...
|
Upcoming Events...
Free Event Posting Service
 More... |
Submit Event |
Event Advertising...
|
|
Learn About Georgia's BioHistory
Why is there a biotechnology industry in Georgia? Will the industry continue
to grow in Georgia? What do other states have? Each state has a unique story
that explains why a given industry has developed in a specific region and not in others.
Through Georgia BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industries in the state of Georgia.
More...
BioEvolution Posters
More...
Flu Season is Here: Learn How to Protect Yourself and Your Loved Ones
Influenza, also called flu, is a contagious respiratory illness caused by
influenza viruses. It can cause mild to severe illness, and at times can lead
to death. The best way to prevent the flu is by getting a flu vaccination each
year.
October through December is the best time to get vaccinated, but getting
vaccinated later in the flu season still provides protection, as flu season
normally peaks in January or later.
More...
BioFact
(100 AD) - Chinese growers use powdered chrysanthemum as the first insecticide.
It's a Small World
|
| |
Lactobacillus Bacteria
| |
Science Quote
"Whenever truth stands in the mind unaccompanied by the evidence upon which it depends, it cannot properly be said to be apprehended at all."
| - |
William Godwin, English political philosopher
|
|
(1756-1836)
|
|
